SBI Large & Midcap Fund
The scheme seeks to provide the investor with the opportunity of long-term capital appreciation by investing in diversified portfolio comprising predominantly large cap and mid cap companies.
Growthvine rating: 5/5 — ranked #3 of 39 in category.
Fund basics
| Category | Equity: Large & Mid Cap |
|---|
| NAV | ₹653.72 (as of 2026-08-21) |
|---|
| AUM | ₹40,850 Cr |
|---|
| Expense ratio | 1.28% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Saurabh Pant |
|---|
| Exit load | 0.1% for redemption within 30 days |
|---|
Performance & risk
| 5-year annualised return | 14.27% |
|---|
| Sharpe ratio | 0.6 |
|---|
| Standard deviation | 13.39% |
|---|
| Max drawdown | -60.96% |
|---|
| Alpha | 1.91 |
|---|
| Beta | 0.88 |
|---|
Over 5 years, captured 88.8% of NIFTY LargeMidcap 250's upside and 76.8% of its downside.
Market cap allocation
| Large cap | 44.9% |
|---|
| Mid cap | 37.1% |
|---|
| Small cap | 18.0% |
|---|
Concentration
| Top 5 holdings | 19.1% |
|---|
| Top 10 holdings | 31.2% |
|---|
| Total holdings | 81 |
|---|
| Index overlap | 27.8% |
|---|
| Active share | 72.2% |
|---|
Top holdings
- HDFC Bank Ltd. — 6.7%
- ICICI Bank Ltd. — 3.9%
- AXIS Bank Ltd. — 3.2%
- State Bank Of India — 2.8%
- Asian Paints Ltd. — 2.5%
- Berger Paints India Ltd — 2.5%
- Adani Enterprises Ltd. — 2.4%
- Bharat Forge Ltd — 2.4%
- Balkrishna Industries Ltd. — 2.4%
- Biocon Ltd. — 2.4%
Top sectors
- Banking & Financial — 20.5%
- Pharma & Biotech — 13.1%
- Automobile — 8.8%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 0.5% | Q3 | #27 of 38 |
| 2025 | 10.1% | Q1 (Top) | #3 of 34 |
| 2024 | 18.0% | Q3 | #20 of 29 |
| 2023 | 26.8% | Q4 (Bottom) | #22 of 28 |
| 2022 | 7.3% | Q1 (Top) | #5 of 28 |